Tobacco use and psychosis risk in persons at clinical high risk
- PMID: 30362261
- PMCID: PMC11531344
- DOI: 10.1111/eip.12751
Tobacco use and psychosis risk in persons at clinical high risk
Abstract
Aim: To evaluate the role of tobacco use in the development of psychosis in individuals at clinical high risk.
Method: The North American Prodrome Longitudinal Study is a 2-year multi-site prospective case control study of persons at clinical high risk that aims to better understand predictors and mechanisms for the development of psychosis. The cohort consisted of 764 clinical high risk and 279 healthy comparison subjects. Clinical assessments included tobacco and substance use and several risk factors associated with smoking in general population studies.
Results: Clinical high risk subjects were more likely to smoke cigarettes than unaffected subjects (light smoking odds ratio [OR] = 3.0, 95% confidence interval [CI] = 1.9-5; heavy smoking OR = 4.8, 95% CI = 1.7-13.7). In both groups, smoking was associated with mood, substance use, stress and perceived discrimination and in clinical high risk subjects with childhood emotional neglect and adaption to school. Clinical high risk subjects reported higher rates of several factors previously associated with smoking, including substance use, anxiety, trauma and perceived discrimination. After controlling for these potential factors, the relationship between clinical high risk state and smoking was no longer significant (light smoking OR = 0.9, 95% CI = 0.4-2.2; heavy smoking OR = 0.3, 95% CI = 0.05-2.3). Moreover, baseline smoking status (hazard ratio [HR] = 1.16, 95% CI = 0.82-1.65) and categorization as ever smoked (HR = 1.3, 95% CI = 0.8-2.1) did not predict time to conversion.
Conclusion: Persons at high risk for psychosis are more likely to smoke and have more factors associated with smoking than controls. Smoking status in clinical high risk subjects does not predict conversion. These findings do not support a causal relationship between smoking and psychosis.
Keywords: clinical high risk; psychosis; schizophrenia; substance use disorder; tobacco.
© 2018 John Wiley & Sons Australia, Ltd.
Figures



Similar articles
-
The association between childhood trauma and tobacco smoking in patients with psychosis, unaffected siblings, and healthy controls.Eur Arch Psychiatry Clin Neurosci. 2024 Oct;274(7):1575-1583. doi: 10.1007/s00406-023-01754-z. Epub 2024 Jan 17. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38231398 Free PMC article.
-
Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early Psychosis.J Dual Diagn. 2018 Apr-Jun;14(2):78-88. doi: 10.1080/15504263.2017.1416436. Epub 2018 Mar 22. J Dual Diagn. 2018. PMID: 29261427
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study.Psychol Med. 2023 Nov;53(15):7265-7276. doi: 10.1017/S0033291723000806. Epub 2023 Apr 26. Psychol Med. 2023. PMID: 37185055
-
Systematic review of tobacco smoking prevalence among young people in treatment for first-episode psychosis.Int J Ment Health Nurs. 2024 Oct;33(5):1381-1387. doi: 10.1111/inm.13332. Epub 2024 Apr 12. Int J Ment Health Nurs. 2024. PMID: 38606655
-
Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment.Mol Psychiatry. 2023 Jun;28(6):2291-2300. doi: 10.1038/s41380-023-02029-8. Epub 2023 Jun 9. Mol Psychiatry. 2023. PMID: 37296309 Free PMC article.
Cited by
-
Complex medical conditions and health risk behaviors among homeless males with schizophrenia.Narra J. 2025 Apr;5(1):e1194. doi: 10.52225/narra.v5i1.1194. Epub 2025 Jan 7. Narra J. 2025. PMID: 40352232 Free PMC article.
-
Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study.Eur Psychiatry. 2021 Sep 21;64(1):e60. doi: 10.1192/j.eurpsy.2021.2233. Eur Psychiatry. 2021. PMID: 34544507 Free PMC article.
-
Cigarette Smoking and Schizophrenia: Etiology, Clinical, Pharmacological, and Treatment Implications.Schizophr Res Treatment. 2021 Dec 13;2021:7698030. doi: 10.1155/2021/7698030. eCollection 2021. Schizophr Res Treatment. 2021. PMID: 34938579 Free PMC article. Review.
-
Occasional cannabis use is associated with higher premorbid functioning and IQ in youth at clinical high-risk (CHR) for psychosis: Parallel findings to psychosis cohorts.Schizophr Res. 2024 Sep;271:319-331. doi: 10.1016/j.schres.2024.07.032. Epub 2024 Jul 30. Schizophr Res. 2024. PMID: 39084107 Free PMC article.
-
Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis.Front Psychiatry. 2023 Apr 20;14:1143315. doi: 10.3389/fpsyt.2023.1143315. eCollection 2023. Front Psychiatry. 2023. PMID: 37151981 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
- T32 ES007018/ES/NIEHS NIH HHS/United States
- P50 MH080272/MH/NIMH NIH HHS/United States
- T32ES007018/ES/NIEHS NIH HHS/United States
- U01 MH081988/MH/NIMH NIH HHS/United States
- P50 MH066286/MH/NIMH NIH HHS/United States
- SCDMH82101008006/Commonwealth of Massachusetts/International
- K24 MH076191/MH/NIMH NIH HHS/United States
- U01 MH082022/MH/NIMH NIH HHS/United States
- U01 MH081984/MH/NIMH NIH HHS/United States
- U01 MH081902/MH/NIMH NIH HHS/United States
- K24 MH76191 P50 MH066286 P50 MH080272R01 MH60720U01 MH081857-05 U01 MH081902 U01 MH081928U01 MH081984 U01 MH081988 U01 MH082004 U01 MH082022/MH/NIMH NIH HHS/United States
- R01 MH060720/MH/NIMH NIH HHS/United States
- U01 MH081928/MH/NIMH NIH HHS/United States
- U01 MH081857/MH/NIMH NIH HHS/United States
- U01 MH082004/MH/NIMH NIH HHS/United States